# Abridge **Source:** https://geo.sig.ai/brands/abridge **Vertical:** Healthcare **Subcategory:** General **Tier:** Emerging **Website:** abridge.com **Last Updated:** 2026-04-22 ## Summary Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation. ## Company Overview Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao. Abridge's ambient clinical documentation platform addresses the documentation burden that drives physician burnout and reduces time available for patient care: physicians spend 35-55% of clinical time on EHR documentation — writing SOAP notes, filling structured encounter data, and completing the after-visit summary — work that occurs before the patient arrives (reviewing records), during the visit (real-time note typing), and after the patient leaves (completing notes, often at home after hours). Abridge's ambient AI (listening to the patient-physician conversation with consent, processing the clinical content, and generating a structured note in the physician's documentation style within minutes of the encounter completing) eliminates the concurrent typing burden and post-visit documentation backlog — returning physicians to eye contact and conversation with patients rather than screen-focused data entry, while generating more complete and accurate notes than manual documentation under time pressure. In 2025, Abridge competes in the ambient clinical AI, healthcare documentation, and physician productivity market with Nuance DAX (Microsoft, NASDAQ: MSFT, ambient clinical AI, largest ambient AI deployment), Suki AI (clinical voice assistant, $70M raised), and Nabla (ambient clinical documentation, $30M raised) for hospital system, health network, and multi-specialty physician group AI clinical documentation and ambient capture platform adoption. The $5.3 billion valuation (Series E, June 2025) places Abridge among the most valuable healthcare AI companies globally. UPMC's 12,000-clinician enterprise deployment demonstrates health system confidence at the scale of the nation's largest integrated health system. The Epic integration advantage (Abridge notes generating directly in Epic workflows with automatic field population) creates the EHR workflow integration that becomes switching-cost-protected once deployed. The 2025 strategy focuses on expanding from physician notes into nursing documentation and care coordinator workflows, building the AI-powered coding accuracy layer (improving ICD-10 code capture from documented encounters), and growing the international health system deployment in the UK NHS and Canadian health authorities. ## Frequently Asked Questions ### What is Abridge? Abridge is a healthcare AI company that uses generative AI to automatically convert patient-clinician conversations into structured clinical notes. The technology saves doctors an average of 3 hours per day by eliminating manual documentation. ### Who are Abridge's customers? Abridge serves health systems and healthcare organizations. The platform is deployed in over 150 health systems including UPMC, Mayo Clinic, Johns Hopkins, and Emory Healthcare, reaching tens of thousands of clinicians. ### When was Abridge founded? Abridge was founded in 2018 by Dr. Shiv Rao, a practicing cardiologist at UPMC in Pittsburgh who experienced firsthand the documentation burden facing physicians. ### Where is Abridge based? Abridge is headquartered in Pittsburgh, Pennsylvania, where it was founded. The company maintains a close relationship with UPMC and Carnegie Mellon University's AI research community. ### How much funding has Abridge raised? Abridge has raised approximately $800 million in total funding, including a $300 million Series E in June 2025 at a $5.3 billion valuation, led by Andreessen Horowitz and Khosla Ventures. ### What makes Abridge different from competitors? Abridge's advantages include deep Epic integration with equity and revenue share partnership, proprietary data from 1.5+ million medical encounters, physician-led development ensuring clinical accuracy, and specialized solutions for different care settings. ### Does Abridge work with Epic? Yes, Abridge has a deep partnership with Epic including equity stake and revenue share arrangement. Abridge Inside is part of Epic's Workshop program, providing preferential access to health systems using Epic EHR. ### How accurate is Abridge? Abridge AI generates notes that clinicians can review and edit before signing. The company's proprietary models are trained on over 1.5 million real medical encounters, ensuring high accuracy across diverse clinical scenarios. ### Is Abridge HIPAA compliant? Yes, Abridge is designed for healthcare environments and maintains HIPAA compliance. The platform includes enterprise security features appropriate for protected health information. ### What clinical specialties does Abridge support? Abridge supports 44+ specialties at UPMC alone, including oncology, cardiology, OB/GYN, neurology, and emergency medicine. The platform continues expanding to new clinical contexts. ## Tags healthtech, b2b, unicorn, ai-powered, north-america --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-22.*